NCT02231788 - The Efficacy of a Combination of Telmisartan/S-Amlodipine Compared With Telmisartan Monotherapy | Biotech Hunter

Enrollment

217

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions

Hypertension

Interventions

DRUG

Telminuvo®Tab. 40/2.5mg

Telminuvo®Tab. 40/2.5mg, Once daily, Per oral for 8weeks after 2\~4weeks run-in period with Telmitrend®Tab. 40mg

DRUG

Telmitrend®Tab. 80mg

Telmitrend®Tab. 80mg, Once daily, Per oral for 8weeks after 2\~4weeks run-in period with Telmitrend®Tab. 40mg

Trial Locations (11)

Korea University Ansan Hospital, Gyeonggi-do

Jeju National University Hospital, Jeju City

Bundang Cha Hospital, Seongnam

Seoul University Bundang Hospital, Seongnam

KyungHee University Medical Center, Seoul

Gangnam Severance Hospital, Seoul

Kumi cha Hospital, Gumi

Seoul University Hospital, Seoul

National Medical Center, Seoul

Kosin University Gospel Hospital, Busan

Hallym University Kangnam Sacred Heart Hosipital, Seoul